tm logo
DARNYTSIA
Live/Pending
RESPONSE AFTER NON-FINAL ACTION - ENTERED

final action

on 10 Dec 2024

Last Applicant/ Owned by

Serial Number

79398507 filed on 08th Jan 2024

Registration Number

N/A

Correspondent Address

Michael G Shariff

Michael G Shariff INVENTA CAPITAL PLC

Bloomfield Hills, MI 48304

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

DARNYTSIA

Health care public relations services, namely, promoting and marketing the goods and services of others in the health care industry through all public communication means; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; disseminati Read More

Classification Information


Class [005]
Pharmaceutical Products


Antiseptics; vaccines; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vitamin preparations; disinfectants; diagnostic preparations for veterinary purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; plant extracts, other than essential oils, for pharmaceutical purposes; herbal extracts, other than essential oils, for medical purposes; capsules sold empty for pharmaceuticals; medicinal preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; drugs for medical purposes being pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medicinal drinks; medicinal oils, other than essential oils; medicated toiletry preparations; medicated shampoos; ointments for pharmaceutical purposes, namely, medicated ointments for treating dermatological conditions and antibiotic ointments; teeth filling material; medicinal alcohol; food supplements; medical dressings; nutritional supplements; syringes sold filled with pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; air purifying preparations; food for babies; protein dietary supplements; tissues impregnated with pharmaceutical lotions for treating dermatological conditions; alcohol for pharmaceutical purposes; stem cells for medical purposes; transplants, namely, surgical implants comprising living tissue used in transplant operations; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ferments for pharmaceutical purposes; phytotherapy preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for medical purposes for the diagnosis of pregnancy; chemical preparations for pharmaceutical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; surgical glues; surgical dressings; medicated sweets; crystallized rock sugar for medical purposes; sanitary preparations for medical purposes; plasters for medical purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [035]
Advertising, Business & Retail Services


Health care public relations services, namely, promoting and marketing the goods and services of others in the health care industry through all public communication means; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; dissemination of advertising matter on communication media relating to health care goods, programs and services; marketing services in the nature of promoting health care goods, programs and services of others


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79398507

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
10th Dec 2024TEAS/EMAIL CORRESPONDENCE ENTERED
09th Dec 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
09th Dec 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
09th Sep 2024REFUSAL PROCESSED BY IB
19th Aug 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17th Aug 2024REFUSAL PROCESSED BY MPU
08th Aug 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07th Aug 2024NON-FINAL ACTION WRITTEN
02th Aug 2024ASSIGNED TO EXAMINER
24th Jul 2024APPLICATION FILING RECEIPT MAILED